A drug that normally suppresses an immune response by trapping lymphocytes in lymphoid organs results in the elimination of a chronic viral infection when applied at low doses. Why should this be?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Premenko-Lanier, M., Moseley, N. B., Pruett, S. T., Romagnoli, P. A. & Altman, J. D. Nature 454, 894–898 (2008).
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. & Ahmed, R. J. Virol. 77, 4911–4927 (2003).
Schwab, S. R. & Cyster, J. G. Nature Immunol. 8, 1295–1301 (2007).
Rosen, H. et al. Immunol. Rev. 223, 221–235 (2008).
Borrow, P., Evans, C. F. & Oldstone, M. B. J. Virol. 69, 1059–1070 (1995).
Mueller, S. N. et al. Proc. Natl Acad. Sci. USA 104, 15430–15435 (2007).
Karrer, U. et al. J. Exp. Med. 185, 2157–2170 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bevan, M., Fink, P. Surprising side effects. Nature 454, 837–838 (2008). https://doi.org/10.1038/454837a
Published:
Issue Date:
DOI: https://doi.org/10.1038/454837a